iv glutathione philadelphia Rehydrate Fast with Hydration Therapy at Home IV Therapy | Philadelphia IV

Protocol 1: moderate weight loss (10-15% body weight) Goal: Steady, sustainable weight loss with minimal side effects Tirzepatide approach: Standard escalation to 5-7.5 mg Hold at the dose where you achieve consistent weekly loss of 0.5-1% body weight Expected timeline: 24-36 weeks to target Likely maintenance dose: 5-7.5 mg Retatrutide approach: Standard escalation to 4 mg 4 mg delivered 12.9% weight loss at 24 weeks in trials Hold at 4 mg if achieving target rate Expected timeline: 20-30 weeks to target For moderate goals, both compounds work well at their lower dose ranges

That's how you know we care

[DOI] [PMC free article] [PubMed] [Google Scholar] 42.Ristow M, Zarse K, Oberbach A, Klting N, Birringer M, Kiehntopf M, Stumvoll M, Kahn CR, Blher M

J Alzheimers Dis 2015;45:985-1000

Boide P, Wagner A, Steinberg H

Bottom line: Dihexa is one of the most potent neurotrophic peptides ever developed, but this same power also makes it potentially dangerous